France’s public health agency is calling on infants, adolescents, and young adults to get vaccinated against meningitis. The appeal comes as the number of infections has risen sharply this year. Health officials emphasize that immunization against certain bacterial strains is essential to prevent this dangerous and potentially deadly disease. Meningococcal infections, caused by bacteria, can result in meningitis—an inflammation of the brain and spinal cord membranes—and severe sepsis. Vaccination campaigns have been launched across the country to curb the spread of these infections.
Significant Increase in Cases France has experienced a notable rise in meningococcal infections this year. In January, 95 cases were reported, followed by 89 in February. These figures are much higher compared to previous years, according to Public Health France. The agency identified two clusters of meningococcal group B infections—the most common strain—among university students in Lyon and within a family and student group in Rennes.
In response, targeted vaccination campaigns are underway, focusing particularly on young people. In 2023, France recorded 615 meningococcal infections, the highest number since 2010. Experts suggest the increase may be linked to the severe flu season, as influenza can raise the risk of developing meningitis.
Vaccination as the Best Prevention Since early 2025, vaccines against meningitis B and serogroups A, C, W, and Y have been mandatory for infants in France. Additionally, the ACWY vaccine is recommended for adolescents aged 11 to 14, with a booster available up to age 24.
Meningitis symptoms include fever, headache, and a stiff neck. Meanwhile, meningococcal sepsis can cause fever, rash, and septic shock. The European Centre for Disease Prevention and Control (ECDC) warns that the disease progresses quickly, with a fatality rate ranging from 8% to 15%.
Outbreaks are rare but often occur in universities or close-knit communities. Vaccination is the most reliable prevention method, while antibiotics can be effective in treatment, according to the ECDC.
Public Health France continues to monitor the situation closely, urging citizens to stay informed and follow vaccination recommendations.